Acalabrutinib in Combination With R-ICE For Relapsed or Refractory Lymphoma

NCT04189952 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Investigator Decision

Conditions

Diffuse Large B Cell Lymphoma
Chronic Lymphocytic Leukemia
Small Lymphocytic Leukemia
Marginal Zone Lymphoma

Interventions

DRUG: Acalabrutinib
DRUG: Rituximab
DRUG: Ifosfamide
DRUG: Carboplatin
DRUG: Etoposide

Sponsor

University of Miami

Collaborators

[object Object]